These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2058 related articles for article (PubMed ID: 32732090)
21. Association of multifocality, tumor number, and total tumor diameter with clinicopathological features in papillary thyroid cancer. Tam AA; Özdemir D; Çuhacı N; Başer H; Aydın C; Yazgan AK; Ersoy R; Çakır B Endocrine; 2016 Sep; 53(3):774-83. PubMed ID: 27090526 [TBL] [Abstract][Full Text] [Related]
22. Predictive Factors for Lymph Node Metastasis in Papillary Thyroid Microcarcinoma. Kim SK; Park I; Woo JW; Lee JH; Choe JH; Kim JH; Kim JS Ann Surg Oncol; 2016 Sep; 23(9):2866-73. PubMed ID: 27075321 [TBL] [Abstract][Full Text] [Related]
23. Papillary thyroid microcarcinomas that metastasize to lymph nodes. Dirikoc A; Tam AA; Ince N; Ozdemir D; Topaloglu O; Alkan A; Yazgan AK; Ersoy R; Cakir B Am J Otolaryngol; 2021; 42(5):103023. PubMed ID: 33838358 [TBL] [Abstract][Full Text] [Related]
24. Predictive factors of lateral lymph node metastasis in solitary papillary thyroid microcarcinoma without gross extrathyroidal extension. Zhang X; Zhang L; Xue S; Wang P; Chen G Asian J Surg; 2019 Apr; 42(4):563-570. PubMed ID: 30078501 [TBL] [Abstract][Full Text] [Related]
25. Clinical and prognosis value of the number of metastatic lymph nodes in patients with papillary thyroid carcinoma. Zhan L; Feng HF; Yu XZ; Li LR; Song JL; Tu Y; Yuan JP; Chen C; Sun SR BMC Surg; 2022 Jun; 22(1):235. PubMed ID: 35725426 [TBL] [Abstract][Full Text] [Related]
26. Pattern of and clinicopathologic risk factors for lateral lymph node metastases in papillary thyroid carcinoma patients with lateral cervical lymphadenopathy. Gong Y; Yang J; Yan S; Su A; Liu F; Gong R; Zhu J; Li Z Medicine (Baltimore); 2018 Sep; 97(36):e12263. PubMed ID: 30200164 [TBL] [Abstract][Full Text] [Related]
27. Bilateral multifocality is an independent predictor of patients' outcome in Middle Eastern papillary thyroid carcinoma. Parvathareddy SK; Siraj AK; Annaiyappanaidu P; Siraj N; Al-Sobhi SS; Al-Dayel F; Al-Kuraya KS Front Endocrinol (Lausanne); 2022; 13():1060301. PubMed ID: 36686467 [TBL] [Abstract][Full Text] [Related]
28. Papillary Thyroid Microcarcinoma: A Nomogram Based on Clinical and Ultrasound Features to Improve the Prediction of Lymph Node Metastases in the Central Compartment. Ye J; Feng JW; Wu WX; Hu J; Hong LZ; Qin AC; Shi WH; Jiang Y Front Endocrinol (Lausanne); 2021; 12():770824. PubMed ID: 35095755 [TBL] [Abstract][Full Text] [Related]
29. Independent predictors and lymph node metastasis characteristics of multifocal papillary thyroid cancer. Genpeng L; Jianyong L; Jiaying Y; Ke J; Zhihui L; Rixiang G; Lihan Z; Jingqiang Z Medicine (Baltimore); 2018 Feb; 97(5):e9619. PubMed ID: 29384841 [TBL] [Abstract][Full Text] [Related]
30. Clinicopathological, immunohistochemical factors and recurrence associated with extrathyroidal extension in papillary thyroid microcarcinoma. Kim WY; Kim HY; Son GS; Bae JW; Lee JB J Cancer Res Ther; 2014; 10(1):50-5. PubMed ID: 24762486 [TBL] [Abstract][Full Text] [Related]
31. Risk factors contributing to the difference in prognosis for papillary versus micropapillary thyroid carcinoma. Karatzas T; Vasileiadis I; Kapetanakis S; Karakostas E; Chrousos G; Kouraklis G Am J Surg; 2013 Oct; 206(4):586-93. PubMed ID: 23790258 [TBL] [Abstract][Full Text] [Related]
32. Skip metastasis in papillary thyroid carcinoma is difficult to predict in clinical practice. Nie X; Tan Z; Ge M BMC Cancer; 2017 Oct; 17(1):702. PubMed ID: 29070029 [TBL] [Abstract][Full Text] [Related]
33. Superior Located Papillary Thyroid Microcarcinoma is a Risk Factor for Lateral Lymph Node Metastasis. Back K; Kim JS; Kim JH; Choe JH Ann Surg Oncol; 2019 Nov; 26(12):3992-4001. PubMed ID: 31264121 [TBL] [Abstract][Full Text] [Related]
34. Risk factors for central neck lymph node metastasis of clinically noninvasive, node-negative papillary thyroid microcarcinoma. Park JP; Roh JL; Lee JH; Baek JH; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY Am J Surg; 2014 Sep; 208(3):412-8. PubMed ID: 24602323 [TBL] [Abstract][Full Text] [Related]
35. The Effects of Hashimoto Thyroiditis on Lymph Node Metastases in Unifocal and Multifocal Papillary Thyroid Carcinoma: A Retrospective Chinese Cohort Study. Zhu F; Shen YB; Li FQ; Fang Y; Hu L; Wu YJ Medicine (Baltimore); 2016 Feb; 95(6):e2674. PubMed ID: 26871795 [TBL] [Abstract][Full Text] [Related]
36. A UK based two-centre review of multifocality and its role in the treatment of papillary thyroid cancer. Li LQ; Hey SY; Andreeva D; Tornari C; Sawant R; Harding NE; Adamson R; Hay A; Simo R; Nixon IJ Eur J Surg Oncol; 2022 Jan; 48(1):14-20. PubMed ID: 34253424 [TBL] [Abstract][Full Text] [Related]
37. Does total tumour diameter, multifocality, number of tumour foci, or laterality predict lymph node metastasis or recurrence in differentiated thyroid cancer? Elbasan O; Ilgın C; Gogas Yavuz D Endokrynol Pol; 2023; 74(2):153-167. PubMed ID: 37039491 [TBL] [Abstract][Full Text] [Related]
38. Influence of Body Mass Index on the Clinicopathologic Features of Papillary Thyroid Carcinoma. Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z Ann Otol Rhinol Laryngol; 2019 Jul; 128(7):625-632. PubMed ID: 30841713 [TBL] [Abstract][Full Text] [Related]
39. Lateral lymph node metastasis in papillary thyroid cancer: Is there a difference between PTC and PTMC? Ma W; Guo Y; Hua T; Li L; Lv T; Wang J Medicine (Baltimore); 2024 Apr; 103(17):e37734. PubMed ID: 38669400 [TBL] [Abstract][Full Text] [Related]
40. Factors Affecting the Locoregional Recurrence of Conventional Papillary Thyroid Carcinoma After Surgery: A Retrospective Analysis of 3381 Patients. Suh YJ; Kwon H; Kim SJ; Choi JY; Lee KE; Park YJ; Park DJ; Youn YK Ann Surg Oncol; 2015 Oct; 22(11):3543-9. PubMed ID: 25743326 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]